Osteoarthritis

Correlation between circulating cell-free mitochondrial DNA content and severity of knee degeneration in patients with knee osteoarthritis: a cross-sectional study

Arthritis Res TherPublished Cross-sectional study

Authors' conclusion

Our study's findings showed that plasma ccf-mtDNA was highly expressed in patients with KOA compared with HC. Furthermore, ccf-mtDNA content is significantly associated with the severity and risk of KOA.

Study context

Population
Patients with knee OA and age-, sex- and body mass index (BMI)-matched healthy controlsKnee osteoarthritis (KOA) and healthy controls (HC)
Participants
60 patients
Exposure
Patients with knee OA vs healthy controls
Outcome
Plasma ccf-mtDNA content (quantitative real-time polymerase chain reaction (qRT-PCR))
Methodological detailsmatched for age, sex and BMI
  • Matched for age, sex and BMI

Main finding

As reported in the abstract

Plasma ccf-mtDNA content

KOA

2.44

median · IQR 1.10–3.79

HC

1.08

median · IQR 0.52–2.12

P < 0.0001

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
KOA risk, highvs low ccf-mtDNALogistic regression4.15 (1.71–10.07)P = 0.002

Circulating cell-free mitochondrial DNA (ccf-mtDNA) across Kellgren-Lawrence (K-L) grades I-IV

Sequential increase from class I to IV (P = 0.040)
Correlation with K-L classification (r = 0.369, P = 0.004)
Correlation with WOMAC scores (r = 0.343, P = 0.007)
  • Spearman analysis

ccf-mtDNA, bilateral vs single KOA

No significant difference (P = 0.083)

KOA risk, high vs low ccf-mtDNA

Quartile analysis: significant dose-dependent association (P trend < 0.001)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Correlation between circulating cell-free mitochondrial DNA content and severity of knee degeneration in patients with knee osteoarthritis: a cross-sectional study. Arthritis Res Ther. Published 18 November 2024. doi:10.1186/s13075-024-03438-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.